SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 10-Q

                                QUARTERLY REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the quarter ended September 30, 2003  Commission file number: 0-28152

                         Affinity Technology Group, Inc.
             (Exact name of registrant as specified in its charter)

                Delaware                                57-0991269
     (State or other jurisdiction of                 (I.R.S. Employer
     incorporation or organization)                 Identification No.)

                         Affinity Technology Group, Inc.
                       1053 B Sparkleberry Lane Extension
                               Columbia, SC 29223
                    (Address of principal executive offices)
                                   (Zip code)

                                 (803) 758-2511
              (Registrant's telephone number, including area code)

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes X No ____

     Indicate by check mark whether the registrant is an  accelerated  filer (as
defined in Rule 12b-2 of the Exchange Act). Yes ____ No X

     Indicate the number of shares  outstanding of each of the issuer's  classes
of common stock, as of the latest practicable date.

41,864,485 shares of Common Stock, $0.0001 par value, as of November 1, 2003.





                AFFINITY TECHNOLOGY GROUP, INC. AND SUBSIDIARIES

                                      INDEX

                                                                                                         PAGE
                                                                                                       
PART I. FINANCIAL INFORMATION
     ITEM 1. Financial Statements
         Condensed Consolidated Balance Sheets as of September 30, 2003 and
             December 31, 2002...................................................................          3
         Condensed Consolidated Statements of Operations for the three and nine months
             ended September 30, 2003 and 2002...................................................          4
         Condensed Consolidated Statements of Cash Flows for the nine months ended
             September 30, 2003 and 2002.........................................................          5
         Notes to Condensed Consolidated Financial Statements....................................          6
     ITEM 2. Management's Discussion and Analysis of Financial Condition and
         Results of Operations...................................................................         10
     ITEM 3. Quantitative and Qualitative Disclosure About Market Risk...........................         14
     ITEM 4. Controls and Procedures.............................................................         14
PART II. OTHER INFORMATION
     ITEM 1. Legal Proceedings...................................................................         15
     ITEM 2. Changes in Securities and Use of Proceeds...........................................         15
     ITEM 6. Exhibits and Reports on Form 8-K....................................................         16
Signature........................................................................................         16




                                       2


Part I.  Financial Information

Item 1.  Financial Statements



                Affinity Technology Group, Inc. and Subsidiaries
                      Condensed Consolidated Balance Sheets

                                                                     September 30,
                                                                         2003              December 31,
                                                                      (Unaudited)              2002
                                                                  -----------------------------------------------
Assets
Current assets:
                                                                                         
  Cash and cash equivalents                                              $     10,372          $    156,780
  Receivables                                                                       -                 5,666
  Other current assets                                                         24,121                42,784
                                                                  -----------------------------------------------
Total current assets                                                           34,493               205,230
  Property and equipment, net                                                  15,872                27,600
  Other assets                                                                  1,365                 2,018
                                                                  -----------------------------------------------
Total assets                                                             $     51,730          $    234,848
                                                                  ===============================================
Liabilities and stockholder's deficiency
Current liabilities:
  Accounts payable                                                       $     74,462          $     20,741
  Accrued expenses                                                            326,179               242,001
  Convertible notes                                                           830,336                     -
  Current portion of deferred revenue                                          17,647                25,000
                                                                  -----------------------------------------------
Total current liabilities                                                   1,248,624               287,742
Convertible notes                                                             225,000               830,336
Deferred revenue                                                               19,118                25,000
Commitments and contingent liabilities Stockholders' deficiency:
  Common stock, par value $0.0001; authorized 60,000,000 shares, issued
     43,622,697 and 43,049,363 shares at
     September 30, 2003 and December 31, 2002, respectively                     4,362                 4,305
  Additional paid-in capital                                               70,498,292            70,441,149
  Common stock warrants                                                        52,000                52,000
  Treasury Stock, at cost (2,168,008 shares at September
      30, 2003 and December 31, 2002)                                      (3,505,287)           (3,505,287)
  Accumulated deficit                                                     (68,490,379)          (67,900,397)
                                                                  -----------------------------------------------
Total stockholders' deficiency                                             (1,441,012)             (908,230)
                                                                  -----------------------------------------------
Total liabilities and stockholder's deficiency                           $     51,730          $    234,848
                                                                  ===============================================


See accompanying notes.


                                       3



                Affinity Technology Group, Inc. and Subsidiaries
                 Condensed Consolidated Statements of Operations
                                   (Unaudited)

                                                           Three months ended                      Nine months ended
                                                             September 30,                           September 30,
                                                         2003             2002                   2003             2002
                                                   -----------------------------------     ----------------------------------

Revenues:
                                                                                                    
    Transactions                                      $           -      $     10,486         $           -     $    104,849
    Patent license revenue                                    4,411                 -                13,235                -
    Other income                                                  -            36,921                     -           51,111
                                                   -----------------------------------     ----------------------------------
       Total revenue                                          4,411            47,407                13,235          155,960
Costs and expenses:
    Cost of revenues                                            442             1,707                 1,324           14,319
    Selling, general and administrative expenses            140,020           262,445               543,686        1,092,731
                                                   -----------------------------------     ----------------------------------
       Total cost and expenses                              140,462           264,152               545,010        1,107,050
                                                   -----------------------------------     ----------------------------------
Operating loss                                             (136,051)         (216,745)             (531,775)        (951,090)
Interest income                                                  32               996                   530              996
Interest expense                                            (20,768)          (18,857)              (58,737)         (53,728)
                                                   -----------------------------------     ----------------------------------
Net loss                                              $    (156,787)     $   (234,606)        $    (589,982)    $ (1,003,822)
                                                   ===================================     ==================================
Net loss per share - basic and diluted:               $       (0.00)     $      (0.01)        $       (0.01)    $      (0.02)
                                                   ===================================     ==================================
Shares used in computing net loss per share              41,454,689        40,881,355            41,404,921       40,648,388
                                                   ===================================     ==================================


See accompanying notes.


                                       4



                Affinity Technology Group, Inc. and Subsidiaries
                 Condensed Consolidated Statements of Cash Flows
                                   (Unaudited)
                                                                               Nine Months Ended
                                                                                 September 30,
                                                                           2003                2002
                                                                   -------------------------------------------
Operating activities
                                                                                       
Net loss                                                                 $ (589,982)         $ (1,003,822)
Adjustments to reconcile net loss to net cash used in
  operating activities:
    Depreciation and amortization                                            12,381               115,210
    Provision for doubtful accounts                                               -                 9,000
    Inventory valuation allowance                                                 -                45,000
    Deferred revenue                                                        (13,235)                    -
    Other                                                                    17,385                63,986
    Changes in current assets and liabilities:
       Accounts receivable                                                    5,666               431,603
       Other current assets                                                  18,663                60,597
       Accounts payable and accrued expenses                                137,899               (80,724)
                                                                   -------------------------------------------
Net cash used in operating activities                                      (411,223)             (359,150)

Investing activities
Sale (purchases) of property and equipment, net                              39,815                (4,044)
                                                                   -------------------------------------------
Net cash provided by (used in) investing activities                          39,815                (4,044)

Financing activities
Proceeds from convertible notes                                             225,000               625,000
Payments on notes payable                                                         -               (38,737)
                                                                   -------------------------------------------
Net cash provided by financing activities                                   225,000               586,263
                                                                   -------------------------------------------
Net (decrease) increase in cash                                            (146,408)              223,069
Cash and cash equivalents at beginning of period                            156,780                27,720
                                                                   -------------------------------------------
Cash and cash equivalents at end of period                               $   10,372          $    250,789
                                                                   ===========================================
Supplemental cash flow information:
    Income taxes paid                                                    $        -          $          -
                                                                   ===========================================
    Interest paid                                                        $        -          $          -
                                                                   ===========================================


See accompanying notes.


                                       5


Notes to Condensed Consolidated Financial Statements

1.   Going Concern

     To date,  Affinity  Technology  Group,  Inc. (the  "Company") has generated
substantial  operating losses,  has experienced an extremely lengthy sales cycle
for its products and services and has been required to use a substantial  amount
of cash  resources  to fund its  operations.  The Company  does not believe that
existing  cash  and  other  anticipated  funds  will be  sufficient  to fund its
operations through February 2004. In addition, principal and accrued interest of
$120,725  under the  convertible  notes  issued by the Company in June 2002 will
become due in June 2004.  Accordingly,  to remain  viable the Company must raise
additional  capital and generate  revenue and working capital through its patent
licensing business, which is in its inception stage. If the Company is unable to
raise additional capital and generate working capital through the sale of patent
licenses very soon, it will be forced to consider  alternatives for winding down
its business,  which may include filing for bankruptcy  protection.  To maintain
the minimal resources  necessary to support its current operations and execute a
patent  licensing  strategy,  the  Company  does not  believe  that  substantial
additional  reductions in its operating expenses are feasible. No assurances can
be given that the Company will be able to raise  additional  capital or generate
working capital from its patent licensing  business in a manner that would allow
it to continue its operations.

     The Company is attempting to secure additional  working capital to continue
its business  activities.  Such action may include the  placement of  additional
debt and/or equity securities.

     There is  substantial  doubt about the  Company's  ability to continue as a
going  concern.  The  financial  statements  do not include any  adjustments  to
reflect the possible future effects on the  recoverability and classification of
assets or amounts and  classification  of liabilities  that may result from this
uncertainty.  However,  management  believes that any adjustments to reflect the
possible future effects on the  recoverability  and classification of assets and
amounts and classification of liabilities would not be material to the Company's
financial position.

2.   Basis of Presentation

     The accompanying  unaudited  financial  statements of the Company have been
prepared in accordance with generally accepted accounting principles for interim
financial  information and with the  instructions to Form 10-Q and Article 10 of
Regulation  S-X.  Accordingly,  they do not include all of the  information  and
footnotes  required by generally  accepted  accounting  principles  for complete
financial  statements.  The balance  sheet at December 31, 2002 has been derived
from the audited  consolidated  financial  statements at that date, but does not
include all of the  information  and  footnotes  required by generally  accepted
accounting principles for complete financial statements.

     The accompanying  unaudited  condensed  consolidated  financial  statements
reflect all adjustments (consisting of normal, recurring accruals) which, in the
opinion of management,  are necessary for a fair presentation of the results for
the  periods  shown.  The  results  of  operations  for  such  periods  are  not
necessarily  indicative  of the  results  expected  for the full year or for any
future  period.  The  accompanying   financial  statements  should  be  read  in
conjunction with the audited  consolidated  financial  statements of the Company
for the year ended December 31, 2002.

     In accordance with management's oversight of the Company's operations,  the
Company  conducts  its  business in one  industry  segment - financial  services
technology (see Note 7).

     Certain  amounts  in  2002  have  been  reclassified  to  conform  to  2003
presentation  for  comparability.  These  reclassifications  have no  effect  on
previously reported stockholders' equity or net loss.

3.   New Accounting Standards

     In December 2002, the Financial  Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 148, "Accounting for Stock Based
Compensation  - Transition  and  Disclosure - an


                                       6


Amendment of FASB Statement No. 123" ("SFAS No. 148").  SFAS No. 148 amends SFAS
No. 123,  "Accounting  for Stock  Based  Compensation,"  to provide  alternative
methods of transition  for a voluntary  change to the fair value based method of
accounting  for stock based  employee  compensation.  In addition,  SFAS No. 148
amends the disclosure requirements of SFAS No. 123 to require in both annual and
interim  financial  statements   prominent   disclosures  about  the  method  of
accounting  for stock based employee  compensation  and the effect of the method
used on reported  results.  The  Company is  required  to follow the  prescribed
disclosure format and has provided the additional  disclosures  required by SFAS
No. 148 for the quarterly period ended September 30, 2003 (see Note 4).

     On January 1, 2003,  the Company  adopted  Financial  Accounting  Standards
Board No. 143,  "Accounting for Asset Retirement  Obligations" ("SFAS No. 143").
SFAS No. 143 provides  guidance on the  recognition  and measurement of an asset
retirement  obligation  and its  associated  retirement  cost.  It also provides
accounting  guidance for legal  obligations  associated  with the  retirement of
tangible  long-lived  assets.  The  adoption of SFAS No. 143 did not  materially
impact the Company's consolidated financial statements.

     In January 2003, the FASB issued  Interpretation No. 46,  "Consolidation of
Variable  Interest  Entities and  Interpretation of ARB No. 51" ("Fin 46"). Many
variable  interest  entities have been commonly  referred to as  special-purpose
entities or off-balance sheet structures,  but this interpretation  applies to a
larger population of entities. In general, a variable interest entity ("VIE") is
any legal  structure used for business  purposes that either:  (1) does not have
equity  investors  with voting rights,  or (2) has equity  investors that do not
provide sufficient financial resources for the entity to support its activities.
Under Fin 46,  the VIE is  required  to be  consolidated  by the  Company if the
Company is subject to a majority  of the risk of loss from the VIE's  activities
or  entitled  to  receive a  majority  of the  entity's  residual  returns.  The
consolidation  requirements  of FIN 46 apply to VIEs created  after  January 31,
2003 and apply to existing  VIEs in the first year or interim  period  beginning
after June 15,  2003.  The  Company  has  adopted  FIN 46, and it did not have a
material impact on the Company's consolidated financial statements.

     In April 2003, the Financial  Accounting  Standards Board issued  Statement
No. 149,  "Amendment  of Statement  133 on  Derivative  Instruments  and Hedging
Activities"  ("SFAS No. 149").  This  statement  amends and clarifies  financial
accounting  and  reporting  for  derivative   instruments,   including   certain
derivative instruments embedded in other contracts  (collectively referred to as
derivatives)  and for  hedging  activities  under  SFAS No.  133.  SFAS No.  149
improves  financial  reporting  by  requiring  that  contracts  with  comparable
characteristics  be accounted for similarly.  In particular,  this statement (1)
clarifies  under what  circumstances  a contract with an initial net  investment
meets the  characteristics  of a  derivative  as  defined by SFAS No.  133,  (2)
clarifies  when a  derivative  contains a  financing  component,  (3) amends the
definition  of an  underlying  to  conform  it to  the  language  used  in  FASB
Interpretation No. 45, "Guarantor's  Accounting and Disclosure  Requirements for
Guarantees,  Including Indirect  Guarantees of Indebtedness of Others",  and (4)
amends certain other existing pronouncements.  Those changes will result in more
consistent  reporting of contracts as either derivatives or hybrid  instruments.
SFAS No. 149 is effective for contracts  entered into or modified after June 30,
2003,  and it did not  have a  material  impact  on the  Company's  consolidated
financial statements.

     In May 2003, the FASB issued  Statement of Financial  Accounting  Standards
No. 150,  "Accounting for Certain Financial  Instruments with Characteristics of
both  Liabilities  and Equity"  ("SFAS No.  150").  This  statement  establishes
standards for how an issuer  classifies  and measures in its financial  position
certain  financial  instruments  with  characteristics  of both  liabilities and
equity.  In accordance  with this standard,  financial  instruments  that embody
obligations  for the issuer are required to be classified as  liabilities.  SFAS
No. 150 is effective for all financial  instruments  entered into on or modified
after  May 31,  2003.  For  existing  financial  instruments,  SFAS  No.  150 is
effective at the beginning of the first interim period  beginning after June 15,
2003. The Company  adopted SFAS No. 150 and there was no material  impact on its
financial position, results of operations or cash flows from adoption.

     In November  2002,  the Financial  Accounting  Standards  Board's  Emerging
Issues  Task  Force  ("EITF")  reached a final  consensus  on Issue  No.  00-21,
"Accounting  for Revenue  Arrangements  with  Multiple  Deliverables",  which is
effective  for revenue  arrangements  entered into in fiscal  periods  beginning
after June 15,  2003.  Under EITF Issue No.  00-21,  revenue  arrangements  with
multiple  deliverables  are  required  to be  divided  into  separate  units  of
accounting under certain circumstances. The Company adopted EITF Issue No. 00-21
on July 1,  2003,  and such


                                       7


adoption did not have a material effect on its condensed  consolidated financial
statements for the three and nine months ended September 30, 2003.

4.   Stock Based Compensation

     The Company  accounts for stock options in accordance  with APB Opinion No.
25,  "Accounting  for Stock Issued to  Employees"  ("APB 25").  Under APB 25, no
compensation  expense is recognized  for stock or stock  options  issued at fair
value.  For stock options  granted at exercise  prices below the estimated  fair
value,  the Company  records  deferred  compensation  expense for the difference
between the  exercise  price of the shares and the  estimated  fair  value.  The
deferred  compensation  expense is amortized  ratably over the vesting period of
the individual options. For performance based stock options, the Company records
compensation expense related to these options over the performance period.

     Statement of Financial  Accounting Standards No. 123, "Accounting for Stock
Based  Compensation"  ("SFAS  123"  as  amended  by  FASB  Statements  No.  148,
"Accounting  for  Stock-Based  Compensation-Transition  and  Disclosure"  ("SFAS
148")),  provides  an  alternative  to  APB 25 in  accounting  for  stock  based
compensation  issued to  employees.  SFAS 123  provides  for a fair value  based
method of accounting for employee stock options and similar equity  instruments.
However,  for companies  that  continue to account for stock based  compensation
arrangements under APB 25, SFAS 123 requires  disclosure of the pro forma effect
on net  income  and  earnings  per  share  as if the  fair  value  based  method
prescribed  by SFAS 123 had been  applied.  The  Company  intends to continue to
account  for  stock  based  compensation  arrangements  under APB No. 25 and has
adopted the pro forma disclosure requirements of SFAS 123.

     Had compensation  cost for options granted under the Company's  stock-based
compensation  plans been  determined  based on the fair value at the grant dates
consistent  with SFAS 123, the Company's net income and earnings per share would
have changed to the pro forma amounts listed below:

                                              Nine Months Ended September 30,
                                                  2003                2002
                                           -------------------------------------
Net loss:
As reported                                      $ (589,982)        $(1,003,822)
Add: stock-based compensation expense
    included in reported net income                       -                   -
Deduct: stock-based compensation expense
    determined under the fair value based
    method for all awards                           (37,186)            (98,862)
                                           -------------------------------------
Pro forma net loss                               $ (627,168)        $(1,102,684)
                                           =====================================
Net loss per common share:
    As reported:
        Basic and diluted                        $    (0.01)        $     (0.02)
    Pro forma:
        Basic and diluted                        $    (0.02)        $     (0.03)


     The pro forma  disclosures  required by SFAS 123 regarding net loss and net
loss per share are stated as if the  Company  had  accounted  for stock  options
using fair values.  Compensation  expense is recognized on a straight-line basis
over the vesting  period of each  option  installment.  Using the  Black-Scholes
option-pricing  model the fair value at the date of grant for these  options was
estimated using the following assumptions:


                                       8


                                         Nine Months Ended September 30,
                                             2003                 2002
                                   ------------------------------------------

Dividend yield                                  -                    -
Expected volatility                          132%                 136%
Risk-free rate of return                    1.99%                4.32%
Expected option life, years                     3                    3


     The weighted  average fair value for options granted under the Option Plans
during the nine months  ended  September  30, 2003 and 2002 was $0.14 and $0.07,
respectively.

     The Black-Scholes and other option pricing models were developed for use in
estimating fair value of traded options,  which have no vesting restrictions and
are fully transferable. In addition,  option-pricing models require the input of
highly  subjective  assumptions.  The  Company's  employee  stock  options  have
characteristics  significantly  different  than  those of  traded  options,  and
changes  in the  subjective  assumptions  can  materially  affect the fair value
estimate.  Accordingly,  in management's opinion,  these existing models may not
necessarily  provide a reliable  single  measure  of the fair value of  employee
stock options.

5.   Net Loss Per Share of Common Stock

     Net loss per share of Common  Stock  amounts  presented  on the face of the
consolidated  statements of operations  have been computed based on the weighted
average  number of shares of Common Stock  outstanding  in  accordance  with the
Statement of Financial Accounting Standards No. 128, "Earnings Per Share." Stock
warrants and stock options were not included in the  calculation of diluted loss
per share because the Company has  experienced  operating  losses in all periods
presented and, therefore, the effect would be anti-dilutive.

6.   Convertible Debenture and Notes

     In June 2002, the Company issued convertible secured notes (the "notes") to
certain  investors as part of its capital  raising  initiatives.  The  principal
amount of notes issued  totaled  $830,336 and included the issuance of a note in
the  principal  amount of  $205,336  to AMRO  International,  S.A.  ("AMRO")  in
satisfaction  of  the  principal  and  accrued  interest   outstanding  under  a
convertible  debenture  previously issued to AMRO. The notes bear interest at 8%
and principal and accrued  interest are due in June 2004.  The notes are secured
by the stock of the Company's  wholly-owned  subsidiary,  decisioning.com,  Inc.
("decisioning.com").   decisioning.com   is  the  Company's   patent   licensing
subsidiary and owns the Company's  patent  portfolio.  The notes are convertible
into the  Company's  common  stock at a conversion  rate of $.20 per share.  The
Company may prepay the notes subject to a prepayment penalty of 8% and 4% if the
prepayment occurs within the first twelve months or thereafter, respectively. In
March 2003,  August 2003 and  November  2003 the  Company  issued an  additional
$200,000,  $25,000 and $150,000,  respectively,  principal amount of convertible
notes on terms  identical to the terms of the notes issued in June 2002,  except
that the new  notes  mature  in March  2005,  August  2005  and  November  2005,
respectively. The notes issued in November 2003 include a $100,000 note acquired
by a subsidiary of The South Financial Group,  which owns  approximately  12% of
the Company's outstanding capital stock.

     On September 22, 2000, the Company entered into a convertible debenture and
warrants purchase  agreement with AMRO. The agreement was amended in August 2001
as  described  below.  Under the original  agreement  on November 22, 2000,  the
Company  issued to AMRO an 8% convertible  debenture in the principal  amount of
$1,000,000. The debenture was convertible, at the option of AMRO, into shares of
the Company's  common stock at a price equal to the lesser of $1.00 per share or
65% of the average of the three lowest  closing  prices of the  Company's  stock
during  the  month  prior to  conversion.  Under  the  original  agreement,  the
debenture  matured on May 22, 2002,  subject to earlier  conversion  and certain
provisions  regarding  acceleration  upon  default  and  prepayment.  Under  the
original  agreement,  on November  22,  2000,  the Company also issued to AMRO a
three-year  warrant to acquire 200,000 shares of the Company's common stock. The
warrant  exercise  price was  originally


                                       9


$0.3542 per share.  AMRO  exercised a portion of the debenture into an aggregate
of 6,214,665 shares of the Company's stock.

     In August 2001, the Company and AMRO amended the convertible  debenture and
warrants  purchase  agreement.  Under the terms of the  amendment,  the  Company
agreed to repay the  debenture in full in a series of monthly  payments  through
June 2002,  and AMRO agreed not to convert  the  debenture  into any  additional
shares of the Company's common stock. In addition,  the Company agreed to reduce
the exercise price of the warrant issued to AMRO from $0.3542 per share to $0.05
per share,  and to reduce the exercise price of a three-year  warrant to acquire
720,000 shares issued to the investor under the Company's  previous  equity line
agreement from $0.8554 per share to $0.05 per share.

     In June 2002, the Company issued to AMRO an 8% convertible  secured note in
the  principal  amount of $205,336 in full  satisfaction  of  remaining  amounts
outstanding  under its  convertible  debenture.  The terms of the 8% convertible
secured  notes are discussed  above.  In October 2003,  AMRO  converted  $74,000
principal  amount and accrued  interest of $7,959 under its secured  convertible
note into an aggregate of 409,796  shares of the Company's  common  stock.  Such
conversion reduced the principal of the convertible  secured note issued to AMRO
to $131,336.

7.   Segment Information

     The Company  conducts its business within one industry  segment - financial
services technology. To date, all revenues generated have been from transactions
with North American customers.  All other segment  disclosures  required by SFAS
131 are included in the consolidated financial statements or in the notes to the
consolidated financial statements.

8.   Commitments and Contingencies

     The Company is subject to legal actions which from time to time have arisen
in the ordinary course of business.  In addition,  a lawsuit has been filed by a
plaintiff who claims  certain  rights,  damages and interests  incidental to the
Company's  formation and development.  The lawsuit initially  resulted in a jury
verdict of $68,000 in favor of the  plaintiff,  and the  plaintiff  subsequently
requested,  and was  granted,  a new trial.  The  Company's  appeal of the order
granting a new trial was denied in August 2003. Accordingly, there will be a new
trial with respect to this action which the Company  expects to occur in January
2004. The plaintiff alleges that the Company breached an agreement to give him a
1% equity  interest in the Company for  services he claims to have  performed in
1993 and 1994.  The  plaintiff  seeks  monetary  damages of  $5,463,000.  In the
opinion of management, the Company has meritorious defenses to this claim.

9.   Subsequent Events

     In November  2003,  the Company  issued an  additional  $150,000  principal
amount of its  convertible  notes.  The notes bear interest at 8%, and principal
and accrued interest are due in November 2005.

     In October 2003,  AMRO  International,  S.A.  converted  $74,000  principal
amount and accrued interest of $7,959 under its secured convertible note into an
aggregate of 409,796  shares of the  Company's  common  stock.  Such  conversion
reduced  the  principal  of the  convertible  secured  note  issued  to  AMRO to
$131,336.

Item 2. Management's  Discussion and Analysis of Financial Condition and Results
        of Operations

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

     Statements in this report (including  Management's  Discussion and Analysis
of Financial  Condition and Results of Operations)  that are not descriptions of
historical  facts,  such as statements  about the Company's future prospects and
cash requirements,  are forward-looking  statements and are made pursuant to the
safe harbor provisions of the Private Securities  Litigation Reform Act of 1995.
Actual results may vary due to risks and uncertainties, including the failure by
the  Company  to raise  additional  capital  or  generate  revenues  in  amounts
sufficient to permit it to continue its operations,  challenges to the Company's
patents,  unanticipated costs and expenses affecting the Company's cash position
and other


                                       10


factors  discussed in the  Company's  filings with the  Securities  and Exchange
Commission,  including  the  information  set forth under the caption  "Business
Risks" in Item 1 of the Company's  Annual Report on Form 10-K for the year ended
December 31, 2002.  These and other  factors may cause actual  results to differ
materially from those anticipated.

Overview

     Affinity  Technology  Group, Inc. (the "Company") was formed to develop and
market  technologies that enable financial  institutions and other businesses to
provide  consumer  financial  services  electronically  with reduced or no human
intervention.  Products and services  previously  offered by the Company include
its  DeciSys/RT(R)  loan processing  system,  which automated the processing and
consummation of consumer financial services transactions; the Affinity Automated
Loan  Machine  (the  ALM(R)),  which  allowed an  applicant to apply for and, if
approved,  obtain a loan in as little as ten minutes;  the Mortgage  ALM,  which
allowed an  applicant  to apply for a  mortgage  loan;  e-xpertLender(R),  which
permitted a financial  institution to make automated  lending  decisions through
its call centers and branches; iDEAL, which permitted automobile lenders to make
automobile  lending  decisions  for loan  applications  originated at automobile
dealers;  and rtDS,  which  permitted  lenders to deliver  credit  decisions  to
applicants  over the  Internet.  Due to capital  constraints,  the  Company  has
suspended all efforts to further  develop,  market and offer these  products and
services.  The Company's last processing  contract  terminated in late 2002, and
the  Company  has no plans in the near term to engage in further  sales or other
activities  related to its  products  or  services,  other  than to license  the
patents that it owns.  Currently,  the  Company's  business  activities  consist
exclusively of attempting to enter into license agreements with third parties to
license the Company's rights under its patents.

     In conjunction with its product development activities, the Company applied
for and  obtained  three  patents.  The  Company  has been  granted  two patents
covering  its  fully-automated  loan  processing  systems  (U.  S.  Patents  No.
5,870,721 and 5,940,811).  In August 2000, the U.S. Patent and Trademark  Office
issued to the Company a patent covering the  fully-automated  establishment of a
financial  account,  including credit accounts (U.S. Patent No.  6,105,007).  In
addition,  in 1997 the  Company  acquired a patent  that  covers  the  automated
processing of an insurance binder through a kiosk (U. S. Patent No. 5,537,315).

     Both of the Company's  patents  covering  fully-automated  loan  processing
systems  have been subject to  reexamination  by the U.S.  Patent and  Trademark
Office  (the  "PTO") due to  challenges  to such  patents by third  parties.  On
January 28, 2003, the Company received a Reexamination Certificate (U. S. Patent
No. 5,870,721 C1) from the PTO which formally  concluded the reexamination of U.
S.  Patent  No.  5,870,721.  The  reexamination  of  the  Company's  other  loan
processing patent (U. S. Patent No. 5,940,811) is still ongoing.  It is possible
that third  parties may bring  additional  actions to contest all or some of the
Company's patents.  The Company can make no assurances that it will not lose all
or some of the claims covered by its existing patents.

     To date,  the Company  has  generated  substantial  operating  losses,  has
experienced  an extremely  lengthy sales cycle for its products and services and
has been  required to use a  substantial  amount of cash  resources  to fund its
operations.   The  Company  does  not  believe  that  existing  cash  and  other
anticipated  funds will be sufficient to fund its  operations  through  February
2004.  In  addition,  principal  and  accrued  interest  of  $120,725  under the
convertible  notes  issued by the  Company in June 2002 will  become due in June
2004.  Accordingly,  to remain viable the Company must raise additional  capital
and generate revenue and working capital through its patent licensing  business,
which is in its inception  stage.  If the Company is unable to raise  additional
capital and generate  working  capital  through the sale of patent licenses very
soon, it will be forced to consider  alternatives for winding down its business,
which may include  filing for  bankruptcy  protection.  To maintain  the minimal
resources  necessary  to support  its  current  operations  and execute a patent
licensing  strategy,  the Company does not believe that  substantial  additional
reductions in its operating  expenses are feasible.  No assurances  can be given
that the Company will be able to raise  additional  capital or generate  working
capital  from its patent  licensing  business in a manner that would allow it to
continue its operations.

     On May  27,  2003,  decisioning.com  entered  into a  legal  representation
agreement  with Withrow &  Terranova,  PLLC,  pursuant to which  decisioning.com
appointed  Withrow & Terranova,  PLLC as its  exclusive  representative  for the
solicitation and negotiation of agreements to license decisioning.com's patents.
(This


                                       11


arrangement  replaced  the  former  patent  licensing  agent  agreement  between
decisioning.com  and  Information  Ventures  LLC  d/b/a  LPS  Group,  which  was
terminated on April 30, 2003.) Under the  agreement,  Withrow & Terranova,  PLCC
has agreed to promote,  market,  solicit, and negotiate the licensing of patents
with  third  parties  and to  represent  decisioning.com  as  legal  counsel  in
connection  with any patent  litigation  associated  with the enforcement of the
patents.  As  compensation  for its  services  under  the  agreement,  Withrow &
Terranova will receive 25% of all revenues received by decisioning.com under any
patent  agreements  and 25% of all  amounts  paid in  settlement  of any  patent
litigation  commenced by the Company.  The term of the agreement is for the life
of the patents,  subject to either  party's right to terminate the agreement for
"cause," as specified in the  agreement,  and without cause  following the third
anniversary of the agreement. If the agreement is terminated by decisioning.com,
Withrow & Terranova,  PLLC will be entitled to continue to receive  compensation
attributable to patent  agreements  negotiated prior to termination and, if such
termination is without cause, compensation for certain future patent agreements.

Critical Accounting Policies

     The Company  applies  certain  accounting  policies,  which are critical in
understanding the Company's results of operations and the information  presented
in the  consolidated  financial  statements.  We  consider  critical  accounting
policies to be those that require more  significant  judgments  and estimates in
the preparation of our financial statements, the most critical of which pertains
to the  valuation  reserve on net  deferred  tax assets.  The Company  records a
valuation  allowance  to reduce its  deferred  tax assets to the amount  that it
estimates is more likely than not to be realized.  As of September  30, 2003 and
December 31, 2002, the Company  recorded a valuation  allowance that reduced its
deferred tax assets to equal its deferred tax liability.

Results of Operations

Revenues

     The Company  recognized  revenues  of $4,411 and  $13,235  from the monthly
amortization of deferred patent license fees for the three and nine months ended
September  30,  2003,  respectively.  The Company has exited all of its previous
business  activities  other than the  licensing  of its patents.  The  Company's
patent  licensing  business is in an early stage.  Revenues  recognized  for the
three and nine months  ended  September  30, 2002,  were  $47,407 and  $155,960,
respectively.  Such revenues  consisted of transaction fees and other income, as
discussed below.

     Transaction fees.  Revenues from transaction fees were $10,486 and $104,849
for the three and nine  months  ended  September  30,  2002,  respectively,  and
consisted of fees charged for services  provided pursuant to the Company's final
loan processing contract. Such contract was terminated in October 2002.

     Other income.  Other income  generally  consists of  miscellaneous  revenue
typically associated with ancillary fees that are non-recurring in nature. Other
income  recognized  for the three and nine  months  ended  September  30,  2002,
respectively,  consisted of  miscellaneous  items  associated with the Company's
final loan processing contract.

Costs and Expenses

     Cost of  Revenues.  Cost of revenues  for the three and nine  months  ended
September  30,  2003 was $442 and $1,324,  respectively,  compared to $1,707 and
$14,319 for the corresponding periods in 2002. The decrease during the three and
nine months ended  September 30, 2003 as compared to the same periods in 2002 is
primarily  attributable  to the Company's  withdrawal  from its activities as an
application  service  provider.  Cost of revenues  incurred during the three and
nine months ended  September 30, 2003,  were  attributable  to  amortization  of
commissions associated with patent licenses.

     Selling,  General  and  Administrative   Expenses.   Selling,  general  and
administrative  expenses  totaled  $140,020  and $543,686 for the three and nine
months ended  September 30, 2003, as compared to $262,445 and $1,092,731 for the
corresponding  periods in 2002. The decrease for the three and nine months ended
September  30,  2003,  as  compared  to the  corresponding  periods  of  2002 is
primarily  attributable to a continued  decrease in


                                       12


employment and related costs associated with an overall  reduction in the number
of employees and reduced overall expense levels.

     Interest  expense.  Interest  expense for the three and nine  months  ended
September 30, 2003, was $20,768 and $58,737,  respectively,  compared to $18,857
and $53,728 for the corresponding  periods in 2002. Interest expense for 2003 is
primarily   associated  with  the  issuance  of  $830,336  principal  amount  of
convertible  notes in June 2002 and  $200,000  principal  amount of  convertible
notes in March 2003.  Interest expense recognized in the third quarter and first
nine months of 2002 is attributable to the Company's convertible notes issued in
June 2002 and a convertible  debenture  formerly held by AMRO.  The  outstanding
balance of this  debenture  of $205,336  was  satisfied in June 2002 through the
issuance of convertible notes as described below.

Liquidity and Capital Resources

     The Company has generated net losses of $68,490,379 since its inception and
has  financed its  operations  primarily  through net proceeds  from its initial
public  offering  in May 1996 and  cash  generated  from  operations  and  other
financing transactions.  Net proceeds from the Company's initial public offering
were $60,088,516.

     To date,  the Company  has  generated  substantial  operating  losses,  has
experienced  an extremely  lengthy sales cycle for its products and services and
has been  required to use a  substantial  amount of cash  resources  to fund its
operations.   The  Company  does  not  believe  that  existing  cash  and  other
anticipated  funds will be sufficient to fund its  operations  through  February
2004.  In  addition,  principal  and  accrued  interest  of  $120,725  under the
convertible  notes issued by the Company in June 2002, as discussed below,  will
become due in June 2004.  Accordingly,  to remain  viable the Company must raise
additional  capital and generate  revenue and working capital through its patent
licensing business, which is in its inception stage. If the Company is unable to
raise additional capital and generate working capital through the sale of patent
licenses very soon, it will be forced to consider  alternatives for winding down
its business,  which may include filing for bankruptcy  protection.  To maintain
the minimal resources  necessary to support its current operations and execute a
patent  licensing  strategy,  the  Company  does not  believe  that  substantial
additional  reductions in its operating expenses are feasible. No assurances can
be given that the Company will be able to raise  additional  capital or generate
working capital from its patent licensing  business in a manner that would allow
it to continue its operations.

     In June 2002, the Company issued convertible secured notes (the "notes") to
certain  investors as part of its capital  raising  initiatives.  The  principal
amount of notes issued  totaled  $830,336 and included the issuance of a note in
the  principal  amount of  $205,336  to AMRO  International,  S.A.  ("AMRO")  in
satisfaction  of  the  principal  and  accrued  interest   outstanding  under  a
convertible  debenture  previously issued to AMRO. The notes bear interest at 8%
and principal and accrued  interest are due in June 2004.  The notes are secured
by  the  stock  of  the  Company's  wholly-owned  subsidiary,   decisioning.com.
decisioning.com  is the  Company's  patent  licensing  subsidiary  and  owns the
Company's patent portfolio.  The notes are convertible into the Company's common
stock at a conversion  rate of $.20 per share.  The Company may prepay the notes
subject to a prepayment penalty of 8% and 4% if the prepayment occurs within the
first twelve months or thereafter,  respectively. In March 2003, August 2003 and
November 2003 the Company  issued an additional  $200,000,  $25,000 and $150,000
principal amount of its convertible notes on terms identical to the terms of the
notes it issued in June 2002,  except  that the new notes  mature in March 2005,
August 2005 and November 2005,  respectively.  The notes issued in November 2003
include a $100,000 note acquired by a subsidiary of The South  Financial  Group,
which owns approximately 12% of the Company's outstanding capital stock.

     In the second  quarter of 2001,  the  Company  issued a $1 million  note to
HomeGold  Financial,  Inc.,  which was secured by the stock of its  wholly-owned
mortgage  subsidiary,  Surety  Mortgage,  Inc.  The note matured on December 31,
2001,  at  which  time  the  Company  tendered  the  stock  of  Surety  in  full
satisfaction  of  outstanding  principal and accrued  interest under the note in
accordance with the terms of the note. The Company had previously entered into a
contract  with  HomeGold  under  which  it  processed   certain   mortgage  loan
applications originated by HomeGold. Such contract expired on December 31, 2001.


                                       13


     In June 2000, the Company entered into an agreement with Redmond Fund, Inc.
("Redmond")  under which Redmond acquired,  for $500,000,  484,848 shares of the
Company's common stock and a three-year warrant to acquire an additional 484,848
shares for $1.37 per share. The warrant has expired.

     On September 22, 2000, the Company entered into a convertible debenture and
warrants purchase  agreement with AMRO. The agreement was amended in August 2001
as  described  below.  Under the original  agreement  on November 22, 2000,  the
Company  issued to AMRO an 8% convertible  debenture in the principal  amount of
$1,000,000. The debenture was convertible, at the option of AMRO, into shares of
the Company's  common stock at a price equal to the lesser of $1.00 per share or
65% of the average of the three lowest  closing  prices of the  Company's  stock
during  the  month  prior to  conversion.  Under  the  original  agreement,  the
debenture  matured on May 22, 2002,  subject to earlier  conversion  and certain
provisions  regarding  acceleration  upon  default  and  prepayment.  Under  the
original  agreement  on November  22,  2000,  the Company  also issued to AMRO a
three-year  warrant to acquire 200,000 shares of the Company's common stock. The
warrant  exercise  price was  originally  $0.3542  per share.  AMRO  exercised a
portion of the debenture into an aggregate of 6,214,665  shares of the Company's
stock.

     In August 2001, the Company and AMRO amended the convertible  debenture and
warrants  purchase  agreement.  Under the terms of the  amendment,  the  Company
agreed to repay the  debenture in full in a series of monthly  payments  through
June 2002,  and AMRO agreed not to convert  the  debenture  into any  additional
shares of the Company's common stock. In addition,  the Company agreed to reduce
the exercise price of the warrant issued to AMRO from $0.3542 per share to $0.05
per share,  and to reduce the exercise price of a three-year  warrant to acquire
720,000 shares issued to the investor under the Company's  previous  equity line
agreement from $0.8554 per share to $0.05 per share.

     In June 2002, the Company issued to AMRO an 8% convertible  secured note in
the principal  amount of $205,336 in full  satisfaction  of amounts  outstanding
under its convertible  debenture.  The terms of the 8% convertible secured notes
are discussed  above. In October 2003, AMRO converted  $74,000  principal amount
and  accrued  interest  of $7,959  under its  secured  convertible  note into an
aggregate of 409,796  shares of the  Company's  common  stock.  Such  conversion
reduced  the  principal  of the  convertible  secured  note  issued  to  AMRO to
$131,336.

     Net cash used during the nine months  ended  September  30,  2003,  to fund
operations  was $441,223  compared to $359,150 for the same period in 2002.  Net
cash  used  during  the nine  months  ended  September  30,  2002  reflects  the
collection of approximately  $432,000 of accounts  receivable in that period. At
September 30, 2003,  cash and liquid  investments  were $10,372,  as compared to
$156,780 at December 31,  2002.  At  September  30, 2003  working  capital was a
deficit of  $1,214,131 as compared to a deficit of $82,512 at December 31, 2002.
Such  deficit  at  September  30,  2003  includes   approximately   $830,000  in
convertible notes which are due in June 2004.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     The  Company  does not  believe  that its  current  business  exposes it to
significant market risk for changes in interest rates.

Item 4. Controls and Procedures

     The Company has carried out an evaluation,  under the  supervision and with
the  participation of the Company's Chief Executive  Officer and Chief Financial
Officer,  of the  effectiveness  of the design and  operation  of the  Company's
disclosure  controls and  procedures as of the end of the period covered by this
report.  Based upon that evaluation,  the Company's Chief Executive  Officer and
Chief Financial  Officer  concluded that the Company's  disclosure  controls and
procedures  were  effective as of  September  30,  2003,  to provide  reasonable
assurances that the  information  required to be disclosed by the Company in its
reports  under the  Securities  Exchange  Act of 1934 was  recorded,  processed,
summarized and reported within the required time periods.

     There  have  been  no  changes  in the  Company's  internal  controls  over
financial  reporting  that  occurred  during the  Company's  most recent  fiscal
quarter that materially affected, or are reasonably likely to materially affect,
the Company's internal control over financial reporting.


                                       14


Part II. Other Information

Item 1. Legal Proceedings

     In June 2003,  the Company  filed a lawsuit  against  Federated  Department
Stores,  Inc.  and  certain of its  subsidiaries  alleging  that  Federated  has
infringed one of the Company's patent (U.S. Patent No. 6,105,007).  In September
2003, the Company filed a similar lawsuit against Ameritrade Holding Corporation
and its subsidiary,  Ameritrade,  Inc. alleging infringement of the same patent.
Both lawsuits were filed in the United States District Court in Columbia,  South
Carolina and both seek unspecified damages.

     Since early 2001,  the Company and  Citibank  N.A.  have been  engaged in a
dispute  involving  amounts  the Company  claims it is owed by Citibank  under a
contract  that the  Company and  Citibank  entered  into in 1997  related to the
development  of  a  system  to  process  automobile  loans.  This  contract  was
transferred by Citibank to The Dime Savings Bank of New York in connection  with
the sale of Citibank's automobile loan business to The Dime Savings Bank. On two
occasions,  Citibank has filed a lawsuit in federal  court in New York seeking a
declaratory  judgment  releasing Citibank from any obligation to the Company for
amounts the  Company  has billed  Citibank  under the  contract.  The first such
action was filed by  Citibank in March 2001,  and such action was  dismissed  in
January 2002 because the court determined that the parties had not complied with
the dispute resolutions  provisions of the contract.  The second such action was
filed in May 2002,  and such action was  subsequently  transferred to the United
States  District  Court in Columbia,  South  Carolina,  on March 11,  2003,  for
consolidation  with the  Company's  pending  lawsuit  against  Citibank.  On two
occasions,  the Company  has filed  actions in federal  court in South  Carolina
seeking to collect amounts it believes it is owed from Citibank.  The first such
action, filed in July 2001, was dismissed by the court in April 2002 because the
court  determined that the parties had not complied with the dispute  resolution
provisions of the contract. The second such action was filed in May 2002, and is
pending.

     The  Company is party to a lawsuit  filed by a  plaintiff  who has  alleged
certain rights,  damages and interests incidental to the Company's formation and
development.  The lawsuit  initially  filed on November 30, 1996,  resulted in a
jury  verdict  of  $68,000  in  favor  of  the  plaintiff,   and  the  plaintiff
subsequently  requested,  and was granted,  a new trial. The Company's appeal of
the order  granting a new trial was denied in August  2003.  Accordingly,  there
will be a new trial with respect to this  action,  which is pending in the Court
of Common  Pleas for the County of Richland in  Columbia,  South  Carolina.  The
trial is  scheduled to occur in January  2004.  The  plaintiff  alleges that the
Company  breached an agreement  to give him a 1% equity  interest in the Company
for services he claims to have performed in 1993 and 1994.  The plaintiff  seeks
monetary  damages of $5,463,000.  In the opinion of management,  the Company has
meritorious defenses to this claim.

Item 2. Changes in Securities and Use of Proceeds

          On August 29, 2003, November 4, 2003 and November 13, 2003 the Company
          issued $25,000, $100,000 and $50,000,  respectively,  principal amount
          of its  convertible  secured notes to a group of accredited  investors
          for cash in transactions exempt from registration  pursuant to Section
          4(2) of the Securities Act of 1933.  These notes are convertible  into
          shares of common stock of the Company at a price of $0.20 per share.

          On October 7, 2003,  the Company  issued  409,796 shares of its common
          stock upon conversion of principal and interest of $81,959 outstanding
          under the  Company's  convertible  notes  issued in June  2002.  These
          shares were issued in a transaction exempt from registration  pursuant
          to Section 3(a)(9) of the Securities Act of 1933.

Items 3, 4 and 5 are not applicable.


                                       15


Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

Exhibit Number      Description
     3.1            Certificate of Incorporation of Affinity  Technology  Group,
                    Inc.,  which is hereby  incorporated by reference to Exhibit
                    3.1 to the  Registration  Statement  on Form S-1 of Affinity
                    Technology Group, Inc. (File No. 333-1170).
     3.2            Bylaws of Affinity  Technology Group,  Inc., which is hereby
                    incorporated by reference to Exhibit 3.2 to the Registration
                    Statement  on Form S-1 of Affinity  Technology  Group,  Inc.
                    (File No. 333-1170).
     31             Rule 13a-14(a)/15d-14(a) Certification
     32             Section 1350 Certification

(b)  Reports on Form 8-K

     None

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

Affinity Technology Group, Inc.

By:  /s/ Joseph A. Boyle
     -------------------
     Joseph A. Boyle
     Chairman, President, Chief Executive Officer and Chief Financial Officer
     (principal executive and financial officer)

Date:  November 14, 2003


                                       16